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Background. Illness predictive scoring systems are significant and meaningful adjuncts
of patient management in the Intensive Care Unit (ICU). They assist in predicting
patient outcomes, improve clinical decision making and provide insight into the
effectiveness of care and management of patients while optimizing the use of hospital
resources. We evaluated mortality predictive performance of Simplified Acute Physiology Score (SAPS 3) and Mortality Probability Models (MPM0 -III) and compared their
performance in predicting outcome as well as identifying disease pattern and factors
associated with increased mortality.
Methods. This was a retrospective cohort study of adult patients admitted to the ICU
of the Aga Khan Hospital, Dar- es- Salaam, Tanzania between August 2018 and April
2020. Demographics, clinical characteristics, outcomes, source of admission, primary
admission category, length of stay and the support provided with the worst physiological
data within the first hour of ICU admission were extracted. SAPS 3 and MPM0 -III scores
were calculated using an online web-based calculator. The performance of each model
was assessed by discrimination and calibration. Discrimination between survivors and
non–survivors was assessed by the area under the receiver operator characteristic curve
(ROC) and calibration was estimated using the Hosmer-Lemeshow goodness-of-fit test.
Results. A total of 331 patients were enrolled in the study with a median age of 58
years (IQR 43-71), most of whom were male (n = 208, 62.8%), of African origin
(n = 178, 53.8%) and admitted from the emergency department (n = 306, 92.4%).
In- hospital mortality of critically ill patients was 16.1%. Discrimination was very good
for all models, the area under the receiver-operating characteristic (ROC) curve for
SAPS 3 and MPM0 -III was 0.89 (95% CI [0.844–0.935]) and 0.90 (95% CI [0.864–
0.944]) respectively. Calibration as calculated by Hosmer-Lemeshow goodness-of-fit
test showed good calibration for SAPS 3 and MPM0 -III with Chi- square values of 4.61
and 5.08 respectively and P–Value > 0.05.
Conclusion. Both SAPS 3 and MPM0 -III performed well in predicting mortality and
outcome in our cohort of patients admitted to the intensive care unit of a private tertiary
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hospital. The in-hospital mortality of critically ill patients was lower compared to studies
done in other intensive care units in tertiary referral hospitals within Tanzania.
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BACKGROUND
The burden of critical care and ICU mortality is greatest in countries with low global
national income (Vincent et al., 2014). The reported ICU mortality widely varies from
one setting to the other with higher rates reported in low and middle-income countries
(LMICs) (Vincent et al., 2014; Ilori & Kalu, 2012; Smith, Ayele & McDonald, 2013). As
of 1st July 2020, the World Bank upgraded Tanzania’s economic status from a low to
lower-middle income country due to its strong economic performance over the past
decade. However, the availability of intensive care units in Tanzania is very limited; none
of the seven district hospitals surveyed in 2009 had an ICU. The four national referral
hospitals had a total of only 38 ICU beds serving a population of 57 million (Baker et al.,
2013). This is in contrast to high-income countries (HICs) which generally have between
five to 30 ICU beds per 100,000 people (Dondorp, Iyer & Schultz, 2016). The availability
and improvement of quality of care of critical illness in LMICs is necessary to reduce
this burden and even more significant in the coming years as the population ages and
prevalence of comorbidities increases (Adhikari et al., 2010).
Despite the use of high-cost and sophisticated devices, ICU mortality rates remain
high. The burden of diseases compounded by a severe lack of resources, specialists and
data makes prediction of ICU outcomes in terms of morbidity and mortality a crucial
component of care across the continent. In HICs mortality prediction models are not only
used to predict outcome but also as tools for quality enhancement and analytical decision
making. These mortality predictive models were developed more than 25 years ago using
patient characteristics. They help quantify the severity of illness, estimate the gravity of
the disease, help predict outcome and assist in resource allocation (Keegan, Gajic & Afessa,
2011; Zimmerman et al., 1995).
The three major predictive scoring systems used to predict mortality in general ICU
patients are the Acute Physiologic and Chronic Health Evaluation (APACHE) scoring
system, the Simplified Acute Physiologic Score (SAPS) and the Mortality Prediction Model
(MPM0 ) (Juneja et al., 2012). APACHE-IV, SAPS 3, and MPM0 -III are the latest versions of
the aforementioned scoring systems (Zimmerman et al., 2006; Metnitz et al., 2005; Higgins
et al., 2007). When selecting a predictive scoring system for use in a given ICU, it is essential
to use a model that is well-proven, established and validated contextually. APACHE-IV has
long been considered more precise for predicting mortality but is perceived as burdensome
and more costly especially in resource-limited settings (Kuzniewicz et al., 2008). MPM0 -III
is considered superior in resource-limited settings since it has the lowest extraction burden
among the three models and is available without cost on various medical information
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sites. MPM0 -III has been a well-studied tool in East Africa. Nevertheless, its performance
in predicting outcomes among critically ill patients admitted to ICU’s in Kenya (Lukoko
et al., 2020) and Rwanda (Riviello et al., 2016) are contradictory. External validation of
SAPS 3 among patients admitted to the ICU’s in Austria, Brazil and Italy reported that
SAPS 3 had a good ability to predict outcomes but performed poorly across all probabilities
of death when compared with APACHE-IV and MPM0 -III (Poole et al., 2009; Nassar Jr
et al., 2012; Metnitz et al., 2009). SAPS 3 may have greater potential for international use
since the score was derived from data in more than one country (Metnitz et al., 2005). No
study to date has assessed the performance of SAPS 3 in LMICs, especially in Sub-Saharan
Africa.
These aforementioned predictive scoring systems have been compared in different
studies and have produced variable results. The existence of a large number of scoring
systems with contrasting performance suggests the best fit model is ICU specific. Thus, each
particular ICU needs to determine which scoring system performs best in its setup; hence
there was a need to carry out a comparative study in our cohort of patients to identify the
best performing model. There have been no studies done in Tanzania that have compared
the performance of these scoring models. The study had two main objectives: (1) To
compare the performance of MPM0 -III and SAPS 3 in order to identify which model best
fits in the ICU of the Aga Khan Hospital, Dar es Salaam. (2) To identify disease patterns
and risk factors associated with higher mortality rates among critically ill patients.

METHODS
This was a single centre retrospective cohort study, conducted in the ICU of the Aga Khan
Hospital, Dar-es- Salaam, Tanzania. The Aga Khan Hospital is the largest private hospital
and the only Joint Commission International (JCI) accredited hospital in Tanzania. The
ICU of the Aga Khan Hospital is a 15 bed unit which provides level III services to all
kind of critically ill patients. The ICU is capable of providing mechanical ventilation,
inotropic support and renal replacement therapy. The unit is divided in 3 sections –7 adult
general ICU beds (including 2 isolation rooms), 4 for cardiac patients and 4 for paediatrics.
The ICU is an open-model one run by a multidisciplinary team comprising of physician
of the primary specialty of care, physiotherapist and dietician led by a full-time critical
care specialist. The nurse-to-patient ratio ranges between 1:1 and 1:2. All adult patients
aged 18 and above admitted to the ICU were eligible for the study. Patients admitted for
observation, having incomplete data and those whose duration of stay in the unit was less
than an hour as well as those diagnosed with COVID–19 were excluded from the study.
Admissions to the ICU are limited to those meeting a strict admitting criteria set by the
hospital. A total of 747 adults patients were admitted to the ICU from August 2018 to
April 2020. A sample size of 331 patients having a specific outcome (death or discharge
home) was determined to be sufficient to give the study a 80% power and 95% confidence
for detection of 10% difference in performance between SAPS 3 and MPM0 -III. The ICU
admission register was used to identify patients admitted and patient files were retrieved
from the medical records. The medical file numbers were entered into a computer and
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computer generated random sampling was performed until the desired sample size was
achieved. Patient demographics and clinical data were extracted using patient records and
were entered into a spreadsheet on Microsoft Office Excel 2010 (Redmond, WA, USA). Data
was extracted by experienced junior doctors with working experience in the ICU and was
independently verified by the primary author for accuracy and completeness. The reasons
for admission were grouped into 11 categories: surgery, gastroenterology, neurology,
endocrinology, respiratory, cardiovascular, nephrology, sepsis, oncology, hematology,
obstetrics and gynecology. When multiple diagnoses were present, the leading one with the
worst prognosis was selected as the main reason for admission.
Descriptive analysis of demographic characteristics were done and presented as
percentages while the categorical and continuous outcome variables were analysed and
presented as means and medians with interquartile ranges respectively. Categorical and
continuous variables between survivors and non-survivors were compared using Pearson’s
chi-square test and Mann–Whitney U test respectively. SAPS-3 and MPM0 -III were
calculated using an online scoring calculator, available on http://www.uptodate.com/.
Accurate discrimination and calibration are key distinguishing features that should be met
by all predictive scoring models. Discrimination of the model was assessed by the area
under the receiver operating characteristic (ROC) curve. An area of 0.7–0.8 is reflected
as fair, 0.8–0.9 good and >0.9 excellent. Non-parametric Wilcoxon statistics was used to
compare the area under the ROC curves (Steyerberg et al., 2010). A Hosmer-Lemeshow
goodness-of-fit test which follows chi-square distribution was used to evaluate the model
fit as well as calibration of the models with a p-value of >0.05 signifying no evidence
of poor fit (Steyerberg et al., 2010). However, all other statistical tests with a p-value of
<0.05 were considered statistically significant. Any variable with P-Value <0.05 and those
considered clinically significant in explaining mortality in the ICU were considered in
multivariable model. Determinants of mortality among critically ill patients were identified
using binary logistic regression; odds ratio with corresponding 95% Confidence intervals
(CI) and P-value were reported. All statistical analysis was done using STATA version 15.
The study protocol was approved by the Ethical Research Committee (ERC) of the Aga
Khan University (AKU/2020/051/fb) and individual consent of each study participant was
exempted since it did not affect the rights and welfare of the patients.

RESULTS
A total of 331 patients were included in the study. Out of the 331 patients (n = 278,
83.9%) survived and (n = 53, 16.1%) died. Table 1 below shows general and clinical
characteristic of the cohort and provides a comparison of survivors to non-survivors.
The median age of the cohort was 58 years (IQR 43-71) with more than half of admitted
patients being male (n = 208, 62.8%) and of African origin (n = 178, 53.8%). Most
of the patients were admitted to the ICU from the emergency department (n = 306,
92.5%), who were at home prior (n = 318, 96.1%) with majority of them suffering from
neurological disease (n = 63, 19%), sepsis (n = 60, 18.1%), respiratory (n = 36, 10.9%) and
cardiovascular (n = 36, 10.9%) related conditions. Median ICU and hospital LOS were 4
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Table 1 General and clinical characteristics of patients (N = 331).
Characteristics

All
(N = 331)

Survivors
(n = 278)

Non-survivors
(n = 53)

N (%)

n (%)

n (%)

Male

208(62.8)

174(62.6)

34(64.2)

Female

123(37.2)

104(37.4)

19(35.8)

p-value

Sex

Age group in years
<45

87(26.3)

79(28.4)

8(15.1)

45–64

114(34.4)

99(35.6)

15(28.3)

65–74

61(18.4)

51(18.4)

10(18.9)

75–84

51(15.4)

36(12.9)

15(28.3)

>84

18(5.4)

13(4.7)

5(9.4)

African

178(53.8)

152(54.7)

26(49.1)

Asian

136(41.1)

111(39.9)

25(47.2)

Other

17(5.1)

15(5.4)

2(3.8)

0.829

0.015

Ethnicity

Admitted from
Emergency

306(92.5)

257(92.5)

49(92.5)

Wards

15(4.5)

12(4.3)

3(5.7)

Clinic

10(3.0)

9(3.2)

1(1.9)

Location before ICU admission
Home
Hospital

0.800

318(96.1)

267(96.0)

51(96.2)

13(3.9)

11(4.0)

2(3.8)

Surgery

38(11.5)

36(12.9)

2(3.8)

Gastroenterology

31(9.4)

25(9.0)

6(11.3)

Neurology

63(19.0)

53(19.1)

10(18.9)

Endocrinology

18(5.4)

17(6.1)

1(1.9)

Respiratory

36(10.9)

35(12.6)

1(1.9)

Cardiovascular

36(10.9)

30(10.8)

6(11.3)

Nephrology

16(4.8)

12(4.3)

4(7.6)

Sepsis

60(18.1)

47(16.9)

13(24.5)

Obstetrics and Gynecology

10(2.0)

9(3.2)

1(1.9)

Hematology

7(2.1)

5(71.4)

2(3.8)

Oncology

16(4.8)

9(3.2)

7(13.2)

40(12.1)

13(4.7)

27(50.9)

Full Code

291(87.9)

265(95.3)

26(49.1)

Age in years

58(43–71)a

55.5(41–70)a

70(55–78)a

SAPS 3 scores

42(32–51)a

39(31–48)a

60(51-68)a

MPM0 III scores

0.950
0.014

Admitting Category

Code Status on Admission
DNR

0.589

3(2–4)

a
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3(2–4)

a

5(4–6)

<0.001
0.0003b
<0.0001b
<0.0001b
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Table 1 (continued)
Characteristics

LOS ICU (days)
LOS Hospital (days)

All
(N = 331)

Survivors
(n = 278)

Non-survivors
(n = 53)

N (%)

n (%)

n (%)

4(2–6)a
6(4–10)a

4(2–6)a
6(4–10)a

6(2–11)a
8(3–13)a

p-value

0.0029b
0.3248b

Notes.
a
median (IQR)
b
p-value for Mann–Whitney U test.
LOS, Length of Stay; DNR, Do Not resuscitate.
Data in median (IQR), and n (%).

(Ilori & Kalu, 2012; Smith, Ayele & McDonald, 2013; Baker et al., 2013; Dondorp, Iyer &
Schultz, 2016; Adhikari et al., 2010) and 6 (Baker et al., 2013; Dondorp, Iyer & Schultz, 2016;
Adhikari et al., 2010; Keegan, Gajic & Afessa, 2011; Zimmerman et al., 1995; Juneja et al.,
2012; Zimmerman et al., 2006) days respectively.
When survivors and non-survivors were compared, there was a statistically significant
difference (P-value <0.05) in age, length of ICU stay, admitting category and code status.
Higher mortality rates were noted in the elderly aged between 75–84 years (n = 15,
28.3%), those suffering from sepsis (n = 13, 24.5%) and neurological diseases (n = 10,
18.9%). Higher percentage of mortality was also noted in Do-Not-Resuscitate (DNR)
patients (n = 27, 50.9%) compared to those without limitations of care. There was no
statistically significant difference between survivors and non-survivors by sex, ethnicity
and prior location before ICU admission. The overall SAPS 3 score for all the patients
was 42 (IQR: 32–51) of which non-survivors had a higher score 60 (IQR: 51–68) than
the survivors 39 (IQR: 31–48) with p-value (<0.0001). Similarly, the median MPM0 -III
score in non-survivors, 5 (IQR: 4–6) was higher than survivors, 3 (IQR: 2–4) with p-value
(<0.0001).
Table 2 below, illustrates the type of support patients received in the first 24 h of ICU
admission. Of the 331 patients admitted to the ICU, (n = 123, 37.2%) patients received
support in the first hour of ICU admission that included: mechanical ventilation, inotropes
and hemodialysis. Highest mortality was noted amongst those who required inotropic
support and mechanical ventilation (n = 21, 39.6%) in the first hour of ICU admission.
Table 3 below highlights comorbid conditions amongst the critical ill patients admitted
to the ICU. More than one comorbid condition per critically ill patient was recorded when
present. The most common comorbid condition amongst our cohort was hypertension
(n = 174, 52.6%) and diabetes mellitus (n = 107, 32.3%).When comorbid conditions were
compared between survivors and non- survivors, a higher percentage of mortality with
statistically significant difference (P value <0.05) was noted among those suffering with
chronic kidney disease (n = 14, 26.4%) and liver cirrhosis (n = 7, 13.2%).
Calibration of each scoring system exhibited good performance. The goodness of fit
Hosmer-Lemeshow test and p-value of each scoring system is shown in Table 4 below. The
area under ROC of SAPS 3 and MPM0 -III in prediction of mortality are shown below in
Fig. 1 below. The area under the ROC was calculated to evaluate the predictive value of
the scoring systems. The area under the ROC curve for the SAPS 3 showed a statistically
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Table 2 Type of support received in the first hour of ICU admission.
Type of support

All
(N = 331)

Survivors
(n = 278)

Non-survivors
(n = 53)

p-value

N (%)

n (%)

n (%)

None

208(62.8)

196(70.5)

12(22.6)

<0.001

Hemodialysis

13(3.9)

11(4.0)

2(3.8)

0.9498

Inotropes

33(10.0)

29(10.4)

4(7.6)

0.5206

Mechanical ventilation

26(7.9)

17(6.1)

9(17.0)

0.0070

Inotropes, Hemodialysis

5(1.5)

5(1.8)

0(0.0)

0.3252

Inotropes, mechanical ventilation

36(10.9)

15(5.4)

21(39.6)

<0.001

Mechanical ventilation, Hemodialysis

3(0.9)

3(1.1)

0(0.0)

0.4474

Inotropes, mechanical ventilation, hemodialysis

7(2.1)

2(0.7)

5(9.4)

0.0001

Notes.
Data presented in n (%).

Table 3 Comorbid conditions among critically ill patients admitted to the ICU.
Comorbidity

All
(N = 331)

Survivors
(n = 278)

Non-survivors
(n = 53)

p-value

N (%)

n (%)

n (%)

Hypertension

174(52.6)

146(52.5)

28(52.8)

0.9553

Diabetes Mellitus

107(32.3)

87(31.3)

20(37.7)

0.3613

Heart Failure

53(16.0)

41(14.7)

12(22.6)

0.1510

Chronic Kidney Disease

45(13.6)

31(11.2)

14(26.4)

0.0030

HIV

21(6.3)

16(5.8)

5(9.4)

0.314

COPD

17(5.1)

15(5.4)

2(3.8)

0.6239

CAD

17(5.1)

15(5.4)

2(3.8)

0.6239

Liver Cirrhosis

16(4.8)

9(3.2)

7(13.2)

0.0022

DM & HTN

87 (26.3)

72 (25.9)

15 (28.3)

0.7157

HTN & CKD

39 (11.8)

27 (9.7)

12 (22.6)

0.0075

DM & HTN & CKD

30 (9.1)

21 (7.6)

9 (17.0)

0.0285

Notes.
Data presented in n (%).

significant predictive marker of mortality (AUC: 0.8892; Severity of illness scoring syst
CI [0.844–0.935]). The cut-off value for SAPS 3 was 54 with the sensitivity of 72% and
specificity of 90%. The MPM0 -III scoring system also showed a statistically significant
predictive marker for the outcome of interest (AUC: 0.904; 95% CI [0.864–0.944]). The
cut-off value for MPM0 -III was 4, with sensitivity of 74% and specificity of 87%. There was
no statistically significant difference between the ROC curves of the two models (P-value
= 0.2418) (Table 5).
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Table 4 Goodness of fit Hosmer-Lemeshow test and p-value of each scoring model.
Scoring Model

Chi –Square

P-Value

MPM 0- III Score

5.08

0.2791

SAPS 3

4.61

0.7980

Figure 1 Receiver operating curve for predicting mortality according to SAPS 3 and MPM0 III models.
Full-size DOI: 10.7717/peerj.12332/fig-1

Table 5 Area under curve and 95% confidence Intervals for the models.
Variable

Cut-off

AUC

LL

UL

P-value
0.2418

MPM 0- III Score

4

0.904

0.864

0.944

SAPS 3

54

0.8892

0.8440

0.935

Notes.
LL, Lower limits; UL, Upper limits; AUC, Area under the ROC curve.

The overall estimated median (IQR) predicted mortality among the 331 ICU patients
was 6% (2%–20%) on the SAPS 3 model and 11.5% (3.8%–27.9%) based on the MPM0 -III
model. The stratified analysis by survivors and non-survivors is shown in Fig. 2 below. The
median predicted mortality risk for survivors is lower than those of non-survivors. In the
SAPS 3 model, the estimated median for survivors was 5% (IQR: 1%–11%) while for the
non-survivors this was 50% (IQR: 34%–69%) Based on the MPM0 -III model the median
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Figure 2 Median predicted mortality rates for SAPS 3 and MPM0 -III.
Full-size

DOI: 10.7717/peerj.12332/fig-2

Table 6 Factors associated with increased odds of mortality among critically ill patients.
Characteristics

Unadjusted odds ratio
OR

95% CI

P-value

Age in years

1.032

1.014-1.051

LOS in ICU

1.068

1.021-1.117

LOS in hospital

1.017

Adjusted odds ratio
OR

95% CI

P-value

0.001

1.020

0.997–1.043

0.086

<0.001

1.462

1.179–1.814

0.001

0.994-1.041

0.141

0.717

0.580–0.886

0.002

0.507-1.723

0.829

0.870

0.399–1.893

0.725

Sex
Male

ref

Female

0.935

Admitted From
Emergency

ref

Wards

1.311

0.357-4.819

0.683

5.341

1.278–22.322

0.022

Clinic

0.583

0.072-4.704

0.612

1.033

0.114–9.347

0.977

0.022-0.102

<0.001

0.052

0.021–0.129

<0.001

Code status
DNR
Full code

ref
0.047

predicted mortality was 9.1% (3.1%−1.7%) and 68.5% (IQR: 42.7%–84.0%) for survivors
and non-survivors respectively.
Multiple clinical factors were associated with increased adjusted odds of mortality. These
included length of ICU stay (adjusted odds ratio [aOR], 1.462; P-Value = 0.001) and those
transferred from the ward (aOR, 5.341; P-value<0.022). However, it was protective to stay
longer in the hospital as the odds of mortality decreased as the length of hospitalization
increased (aOR, 0.717; P-Value = 0.002) (Table 6).
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DISCUSSION
To our knowledge, this is the first study to report on performance of predictive scoring
models in Tanzania and more so in a private setting. Accurate discrimination and calibration
are two key characteristics that should be met by all predictive scoring systems. Both SAPS
3 and MPM0 -III performed well in our cohort. According to our results, a SAPS 3 score
of higher than 54 can predict mortality with sensitivity of 72% and specificity of 90%.
A MPM0 -III score of greater than 4 can predict mortality with sensitivity of 74% and
specificity of 87%.
Discrimination describes the accuracy of a given prediction in our cohort, the
discriminatory capability of both SAPS 3 (20 variables) and MPM0 -III (16 variables)
was good. There was no statistically significance difference when both these models were
compared, suggesting that the model with more variables was not associated with better
discriminatory performance. MPM0 -III has been externally validated in various ICUs in
North America (Higgins et al., 2007; Kuzniewicz et al., 2008; Higgins et al., 2009) and has
shown to have good discrimination which was similar to our study finding. However, a
study done at Aga Khan University Hospital, Nairobi, Kenya (Lukoko et al., 2020) and two
public ICUs in Rwanda (Riviello et al., 2016) showed MPM0 -III to have fair discrimination
amongst their cohort. This observed difference in discrimination may be due to the
effect of differences in proportion of case mixes between the study settings. Similarly
SAPS 3 has been externally validated in various ICUs in Italy (Poole et al., 2009), Brazil
(Nassar Jr et al., 2012), Austria (Metnitz et al., 2009) and found to have good discriminatory
capability amongst their cohort. Despite SAPS 3 having greater prospective for international
generalizability there has been no published studies evaluating its performance in SubSaharan African ICUs. This is the first study that reports its potential for application in
LMICs.
Calibration describes how the instrument performs over a wide range of predicted
mortalities. Calibration is sensitive to alterations in case-mix and patient care and
interventions. Despite its tendency to deteriorate over time and leading to overestimation of
mortality (Nassar Jr et al., 2012), both SAPS 3 and MPM0 -III were well calibrated amongst
the critically ill patients admitted at our study setting. Our study findings were contrary
to SAPS 3 validation studies mentioned earlier which reported poor calibration and
overestimation of mortality (Poole et al., 2009; Nassar Jr et al., 2012; Metnitz et al., 2009).
However, external validation studies have reported MPM0 -III to have good calibration
(Higgins et al., 2007; Kuzniewicz et al., 2008; Higgins et al., 2009). Earlier studies mentioned
that were conducted in Sub-Saharan Africa have produced contrasting results. The MPM0 III was well calibrated amongst the critical ill patients admitted to the ICU of the Aga Khan
University Hospital, Nairobi (Lukoko et al., 2020) but showed poor calibration amongst all
adult patients admitted to Rwanda’s two public ICUs (Riviello et al., 2016). These findings
highlight the similar treatment protocols and interventions between two sister hospitals
located in different geographical regions.
In this retrospective study we also aimed to identify patient demographics, disease
patterns, clinical outcomes as well as factors associated with higher risk of mortality in
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patients admitted to the ICU of the Aga Khan Hospital, Dar –es Salaam. Based on this
retrospective observational cohort, the in-hospital mortality of critically ill patients was
16.1%, which is far less than the reported mortality among all other tertiary referral hospitals
in Tanzania, 41.4% (Sawe et al., 2014) but slightly exceeds rates reported in western Europe
and North America (Vincent et al., 2014). This disparity is not surprising since the intensive
care unit at our setting has access to more resources than similar units in the country and
comparable in various ways to facilities in HICs. The ICU cohort studied in the four tertiary
referral hospitals in Tanzania was younger (median age 34 years, IQR 21-53) compared to
our study population (median age 58 years, IQR 43–71). This variation could be due to
the exclusion of patients aged less than 18 years in our study. However both the cohorts
had male predominance of 57.5% and 62.8% respectively (Sawe et al., 2014). The bulk of
admissions in our cohort were those suffering from neurological disease, sepsis, respiratory
and cardiovascular related conditions. Mortality was highest among those admitted due to
sepsis. Our results are in parallel with a large intercontinental database that emphasized
the association of sepsis with high mortality rates in all countries (Vincent et al., 2014).
The median length of ICU stay is similar to reports from tertiary hospitals in Sub-Saharan
Africa (Sawe et al., 2014; Kwizera, Dunser & Nakibuuka, 2012).
Prolonged length of stay (LoS) in the ICU and patients transferred from the general ward
to the ICU were factors associated with higher adjusted odds of mortality among critically
ill patients. Prolonged LoS in the ICU may be attributed to development of multi- systemic
complications necessitating continued organ support. There are no laws and guidelines
in Tanzania with regards to withdrawal of support, hence we hypothesize that significant
fraction of patients with a prolonged course of illness and with expected poor outcomes
are admitted for extended intervals before succumbing to death. Our study findings are
comparable to several studies done in well-equipped ICUs that concluded patients with
multiple diseases and having organ dysfunction were key factors that prolong the LoS in
ICU (Toptas et al., 2018; Moitra et al., 2016). Contrasting results have also been published
that LoS in ICU is not an independent risk factor for in-hospital mortality (Williams et
al., 2010). Those patients transferred from the general ward to the ICU also had higher
adjusted odds of mortality; this is not surprising since it is a mere reflection of deteriorating
physiological and clinical condition. Few studies have demonstrated early transfer to the
ICU for treatment to have a substantial impact on in-hospital mortality and LoS (Churpek
et al., 2016; Young et al., 2003).
We identified several limitations in our study. Firstly, this was a single center study and
as such the findings may not be valid across all patient populations in Tanzania. Secondly,
since our study was a retrospective design it restricted us the ability to follow up outcomes
after ICU discharge and doesn’t provide the same level of evidence as a prospective study
design.

CONCLUSION
In summary, this is the first and largest study to report on performance of predictive scoring
models in Tanzania. Our study concluded both SAPS 3 and MPM0 -III performed well in
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predicting mortality well among critically ill patients admitted to the ICU of the Aga Khan
Hospital, Dar es Salaam, Tanzania. We found our mortality among critically ill patients
to be much lower compared to other tertiary referral hospitals in Tanzania. Amongst our
cohort, patients with sepsis had the highest mortality rate. Thus clinical research targeting
infection prevention efforts and early implementation of targeted interventions would be
important to improving outcomes. Prolonged ICU stay and transfer from general wards to
ICU were key factors of mortality. Of note, the performance of predictive scoring models
tend to deteriorate over time; termed as worsening of discrimination and calibration and
resulting in overestimation of mortality (Nassar Jr et al., 2012). Thus periodic updating is
crucial for sustaining accuracy of these predictive models.
Abbreviations
APACHE
SAPS
MPM
LoS
ICU

Acute physiology and chronic health evaluation
Simplified acute physiology score
Mortality probability models
Length of Stay
Intensive care Unit

ACKNOWLEDGEMENTS
Special thanks to Dr. Kamran Hameed, head of the Internal Medicine department at the
Aga Khan University and Hospital, Dar-es-Salaam for his continuous mentorship and
guidance during my residency program.

ADDITIONAL INFORMATION AND DECLARATIONS
Funding
The authors received no funding for this work.

Competing Interests
The authors declare there are no competing interests .

Author Contributions
• Nadeem Kassam conceived and designed the experiments, performed the experiments,
prepared figures and/or tables, authored or reviewed drafts of the paper, and approved
the final draft.
• Eric Aghan, Samina Somji, Omar Aziz and Salim R. Surani conceived and designed the
experiments, performed the experiments, authored or reviewed drafts of the paper, and
approved the final draft.
• James Orwa analyzed the data, prepared figures and/or tables, authored or reviewed
drafts of the paper, and approved the final draft.

Kassam et al. (2021), PeerJ, DOI 10.7717/peerj.12332

12/15

Human Ethics
The following information was supplied relating to ethical approvals (i.e., approving body
and any reference numbers):
The Study was approved by the Aga Khan University Ethical research committee
(AKU- ERC, EA): AKU/2020/051/fb. The National Institute for Medical Research (NIMR)
mandates the AKU –ERC to approve health research conducted by Tanzanian staff and
students under the Act of Parliament No. 23 of 1979 and its amendments in 1997.

Ethics
The following information was supplied relating to ethical approvals (i.e., approving body
and any reference numbers):
The Study was approved by the Aga Khan University Ethical research committee
(AKU- ERC, EA): AKU/2020/051/fb. The National Institute for Medical Research (NIMR)
mandates the AKU –ERC to approve health research conducted by Tanzanian staff and
students under the Act of Parliament No. 23 of 1979 and its amendments in 1997.

Data Availability
The following information was supplied regarding data availability:
Raw data is available as a Supplementary File.

Supplemental Information
Supplemental information for this article can be found online at http://dx.doi.org/10.7717/
peerj.12332#supplemental-information.

REFERENCES
Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. 2010. Critical care and
the global burden of critical illness in adults. Lancet 376(9749):1339–1346
DOI 10.1016/S0140-6736(10)60446-1.
Baker T, Lugazia E, Eriksen J, Mwafongo V, Irestedt L, Konrad D. 2013. Emergency
and critical care services in Tanzania: a survey of ten hospitals. BMC Health Services
Research 13:140 DOI 10.1186/1472-6963-13-140.
Churpek MM, Wendlandt B, Zadravecz FJ, Adhikari R, Winslow C, Edelson DP.
2016. Association between intensive care unit transfer delay and hospital mortality: a multicenter investigation. Journal of Hospital Medicine 11(11):757–762
DOI 10.1002/jhm.2630.
Dondorp AM, Iyer SS, Schultz MJ. 2016. Critical care in resource-restricted settings.
JAMA 315(8):753–754 DOI 10.1001/jama.2016.0976.
Higgins TL, Kramer AA, Nathanson BH, Copes W, Stark M, Teres D. 2009. Prospective
validation of the intensive care unit admission Mortality Probability Model (MPM0III). Critical Care Medicine 37(5):1619–1623 DOI 10.1097/CCM.0b013e31819ded31.
Higgins TL, Teres D, Copes WS, Nathanson BH, Stark M, Kramer AA. 2007. Assessing contemporary intensive care unit outcome: an updated Mortality Probability Admission Model (MPM0-III). Critical Care Medicine 35(3):827–835
DOI 10.1097/01.CCM.0000257337.63529.9F.

Kassam et al. (2021), PeerJ, DOI 10.7717/peerj.12332

13/15

Ilori IU, Kalu QN. 2012. Intensive care admissions and outcome at the University of
Calabar Teaching Hospital, Nigeria. Journal of Critical Care 27(1):105 e1–4.
Juneja D, Singh O, Nasa P, Dang R. 2012. Comparison of newer scoring systems with
the conventional scoring systems in general intensive care population. Minerva
Anestesiologica 78(2):194–200.
Keegan MT, Gajic O, Afessa B. 2011. Severity of illness scoring systems in the intensive
care unit. Critical Care Medicine 39(1):163–169
DOI 10.1097/CCM.0b013e3181f96f81.
Kuzniewicz MW, Vasilevskis EE, Lane R, Dean ML, Trivedi NG, Rennie DJ, Clay T,
Kotler PL, Dudley RA. 2008. Variation in ICU risk-adjusted mortality: impact
of methods of assessment and potential confounders. Chest 133(6):1319–1327
DOI 10.1378/chest.07-3061.
Kwizera A, Dunser M, Nakibuuka J. 2012. National intensive care unit bed capacity and
ICU patient characteristics in a low income country. BMC Research Notes 5:475
DOI 10.1186/1756-0500-5-475.
Lukoko LN, Kussin PS, Adam RD, Orwa J, Waweru-Siika W. 2020. Investigating, SOFA,
delta-SOFA and MPM-III for mortality prediction among critically ill patients at
a private tertiary hospital ICU in Kenya: a retrospective cohort study. PLOS ONE
15(7):e0235809 DOI 10.1371/journal.pone.0235809.
Metnitz B, Schaden E, Moreno R, Le Gall JR, Bauer P, Metnitz PG, ASDI Study Group.
2009. Austrian validation and customization of the SAPS 3 Admission Score.
Intensive Care Medicine 35(4):616–622 DOI 10.1007/s00134-008-1286-2.
Metnitz PG, Moreno RP, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G,
Edbrooke D, Capuzzo M, Le Gall JR, SAPS3 Investigators. 2005. SAPS 3–From
evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives,
methods and cohort description. Intensive Care Medicine 31(10):1336–1344
DOI 10.1007/s00134-005-2762-6.
Moitra VK, Guerra C, Linde-Zwirble WT, Wunsch H. 2016. Relationship between
ICU length of stay and long-term mortality for elderly ICU survivors. Critical Care
Medicine 44(4):655–662 DOI 10.1097/CCM.0000000000001480.
Nassar Jr AP, Mocelin AO, Nunes AL, Giannini FP, Brauer L, Andrade FM, Dias
CA. 2012. Caution when using prognostic models: a prospective comparison of 3 recent prognostic models. Journal of Critical Care 27(4):423 e1–7
DOI 10.1016/j.jcrc.2011.08.016.
Poole D, Rossi C, Anghileri A, Giardino M, Latronico N, Radrizzani D, Langer M,
Bertolini G. 2009. External validation of the Simplified Acute Physiology Score
(SAPS) 3 in a cohort of 28, 357 patients from 147 Italian intensive care units.
Intensive Care Medicine 35(11):1916–1924 DOI 10.1007/s00134-009-1615-0.
Riviello ED, Kiviri W, Fowler RA, Mueller A, Novack V, Banner-Goodspeed VM,
Weinkauf JL, Talmor DS, Twagirumugabe T. 2016. Predicting mortality in lowincome country ICUs: the rwanda mortality probability model (R-MPM). PLOS
ONE 11(5):e0155858 DOI 10.1371/journal.pone.0155858.

Kassam et al. (2021), PeerJ, DOI 10.7717/peerj.12332

14/15

Sawe HR, Mfinanga JA, Lidenge SJ, Mpondo BC, Msangi S, Lugazia E, Mwafongo V,
Runyon MS, Reynolds TA. 2014. Disease patterns and clinical outcomes of patients
admitted in intensive care units of tertiary referral hospitals of Tanzania. BMC
International Health and Human Rights 14:26 DOI 10.1186/1472-698X-14-26.
Smith ZA, Ayele Y, McDonald P. 2013. Outcomes in critical care delivery at Jimma University Specialised Hospital, Ethiopia. Anaesthesia and Intensive Care 41(3):363–368
DOI 10.1177/0310057X1304100314.
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina
MJ, Kattan MW. 2010. Assessing the performance of prediction models: a
framework for traditional and novel measures. Epidemiology 21(1):128–138
DOI 10.1097/EDE.0b013e3181c30fb2.
Toptas M, Sengul Samanci N, Akkoc I, Yucetas E, Cebeci E, Sen O, Can MM, Ozturk
S. 2018. Factors affecting the length of stay in the intensive care unit: our clinical
experience. BioMed Research International 2018:9438046.
Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman
J, Reinhart K, Antonelli M, Pickkers P, Njimi H, Jimenez E, Sakr Y, ICON Investigators. 2014. Assessment of the worldwide burden of critical illness: the intensive
care over nations (ICON) audit. The Lancet Respiratory Medicine 2(5):380–386
DOI 10.1016/S2213-2600(14)70061-X.
Williams TA, Ho KM, Dobb GJ, Finn JC, Knuiman M. 2010. Royal Perth Hospital ICU
Data Linkage Group, Effect of length of stay in intensive care unit on hospital and
long-term mortality of critically ill adult patients. British Journal of Anaesthesia
104(4):459–464 DOI 10.1093/bja/aeq025.
Young MP, Gooder VJ, McBride K, James B, Fisher ES. 2003. Inpatient transfers to the
intensive care unit: delays are associated with increased mortality and morbidity.
Journal of General Internal Medicine 18(2):77–83
DOI 10.1046/j.1525-1497.2003.20441.x.
Zimmerman JE, Kramer AA, McNair DS, Malila FM. 2006. Acute Physiology
and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment
for today’s critically ill patients. Critical Care Medicine 34(5):1297–1310
DOI 10.1097/01.CCM.0000215112.84523.F0.
Zimmerman JE, Wagner DP, Knaus WA, Williams JF, Kolakowski D, Draper EA.
1995. The use of risk predictions to identify candidates for intermediate care
units. Implications for intensive care utilization and cost. Chest 108(2):490–499
DOI 10.1378/chest.108.2.490.

Kassam et al. (2021), PeerJ, DOI 10.7717/peerj.12332

15/15

